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Background. Accumulating evidence supports leukocyte telomere length (LTL) as a biological marker of cellular aging. Poor sleep
is a risk factor for age-related disease; however, the extent to which sleep accounts for variation in LTL is unknown. Methods.T h e
presentstudyexaminedassociationsofself-reportedsleepduration,onsetlatency,andsubjectivequalitywithLTLinacommunity-
dwellingsampleof245healthywomeninmidlife(aged49–66years).Results.Whilesleepdurationandonsetlatencywereunrelated
to LTL, women reporting poorer sleep quality displayed shorter LTL (r = 0.14, P = 0.03), independent of age, BMI, race, and
income (b = 55.48, SE = 27.43, P = 0.04). When analyses were restricted to participants for whom sleep patterns were chronic,
poorer sleep quality predicted shorter LTL independent of covariates and perceived psychological stress. Conclusions. This study
provides the ﬁrst evidence that poor sleep quality explains signiﬁcant variation in LTL, a marker of cellular aging.
1.Introduction
The elderly (65 year or older) population is growing at a re-
markable rate, expected to exceed 72 million in the United
States by 2030 [1]. This growth is likely to lead to increasing
prevalence in age-related disease, including cardiovascular
disease, diabetes, and various forms of cancer. The burden of
this population on the health care system will be formidable,
thus, highlighting the importance of identifying markers of
cellular aging implicated in the onset and progression of
disease. Emerging evidence supports telomere length as a
correlate and potential mechanism underling rates of dis-
eases. Telomeres are DNA-protein complexes that cap chro-
mosomal ends, conferring chromosomal stability [2, 3].
Shorter leukocyte telomere length is a putative risk fac-
tor for several chronic conditions, including hyperten-
sion [4], atherosclerosis [5], type 2 diabetes mellitus [6,
7], and predicts risk for cardiovascular and all-cause
mortality [8–10].
There are several psychological and behavioral factors
associated with telomere length, including psychological dis-
tress [11], personality characteristics [12], poor diet [13],
cigarette smoking [14, 15], and leading a sedentary lifestyle
[16, 17]. Interestingly, sleep, a modiﬁable health behavior
that often worsens with age [18] and is repeatedly pre-
dictive of rates of chronic disease [19–21], has yet to be
evaluated. Prior laboratory and epidemiologic evidence sup-
ports associations between disrupted sleep and several plau-
sible biological pathways to disease, including alterations
in cellular immune function [22]; however, this work has
not extended to markers of cellular aging, such as telomere
length.
The aim of the current study was to examine the as-
sociations of sleep duration and sleep quality with leukocyte
telomere length (LTL) in a sample of healthy women in2 Journal of Aging Research
midlife. Based on the existing sleep literature, it was hy-
pothesized that shorter sleep duration and poorer sleep
quality would be related to shorter LTL.
2. Methods
2.1.Participants. Twohundredandsixty-threehealthywom-
en between the ages of 50 and 65 were recruited through
ﬂyers and posters in the San Francisco Bay Area. Participants
are part of an ongoing prospective study on telomere length
change over the course of a year, examining the eﬀects of
knowing one’s telomere length on behavior and psychologi-
cal stress. Participants were excluded from the study if they
had (a) any cancer diagnosis within the past 5 years, (b)
any cancer treatment, including chemotherapy, radiation,
and/or long-term immunosuppressant therapy, within the
past 10 years, (c) diagnosis of autoimmune disorder (e.g.,
rheumatoid arthritis), or (d) current smoker status. Fifteen
participants with lifetime histories of cancer were further
excluded from this study. Participants were free of serious
illness as assessed by self-report at time of participation. In
the current study, two additional participants had missing
LTL, and one was missing subjective sleep quality, leaving
245 participants with complete data. The study protocol was
approved by the Institutional Review Board of the University
of California, San Francisco.
2.2. Procedure. Interested women who met eligibility criteria
by telephone screening provided written, informed consent
upon arrival at the ﬁrst visit. All women participated in a
morning fasting blood draw for LTL measurement. Trained
research assistants then completed anthropometric mea-
surements on all women in a separate room. Finally, they
completedabatteryofsociodemographic,psychological,and
health behavior questionnaires immediately after eating a
provided breakfast.
2.3. Sleep Measures. Measures of self-reported sleep were
obtained using questions adapted from the Pittsburgh Sleep
Quality Index [23]. Speciﬁcally, participants were asked to
respond to the following regarding their sleep in the past
week: “When have you usually gone to bed at night?”; “How
longinminuteshasitusuallytakentofallasleepeachnight?”;
“When have you usually gotten up in the morning?”; “How
manyhoursofactualsleepdidyougetpernight?”;and“How
would you rate your sleep quality overall?” ((1) very bad to
(5) very good), thereby, providing self-report measures of
time in bed, duration, sleep onset latency, and sleep quality,
respectively. These single-item sleep measures are common
in epidemiologic studies and have been linked to a variety of
negative health outcomes [24–27]. Finally, participants were
askediftheirsleeppatternsoverthepastweekrepresenttheir
typical sleep pattern over the past 3 months (typical versus
atypical). This provided important information regarding
the chronicity of the reported sleep measures.
2.4. Psychological Measures. Participants also completed the
Perceived Stress Scale [28] to assess levels of psychological
stress. This 10-item measure is widely used for assessing
stress perceptions, including ratings of feeling overwhelmed,
out of control, and stressed over the past month.
2.5. Leukocyte Telomere Length. Fasting morning blood
was collected in 10-mL heparin tubes (Becton-Dickinson,
Franklin Lakes, NJ, USA). Whole blood was stored in 1mL
aliquots in screw-cap eppendorf tubes at −80◦C, and DNA
was prepared in batches using QIAamp blood mini kit
(QIAGEN Inc.). Telomere length was measured by qPCR
adapted from the published methods by Cawthon [29]a n d
Lin et al. [30]. Carried out on a Roche Lightcycler 480
real-time PCR machine with 384-tube capacity (Roche
Diagnostics Corporation, Indianapolis, IN), the telomere
thermal cycling proﬁle consists of cycling for T(telomeric
DNA) PCR: denature at 96◦C for 1 second, anneal/extend
at 54◦C for 60 seconds, with ﬂuorescence data collection,
30 cycles. Cycling for S (single copy gene) PCR: denature
at 95◦C for 15 seconds, anneal at 58◦C for 1 second,
extend at 72◦C for 20 seconds, 8 cycles, followed by
denaturing at 96◦C for 1 second, annealing at 58◦Cf o r1
second, extending at 72◦C for 20 seconds, holding at 83◦C
for 5 seconds with data collection, 35 cycles. The primers for
the telomere PCR are tel1b (5 -CGGTTT(GTTTGG)5GTT-
3 ), used at a ﬁnal concentration of 100nM, and tel2b
(5 GGCTTG(CCTTAC)5CCT-3 )u s e da taﬁ n a lc o n c e n -
tration of 900nM. The primers for the single-copy
gene (human beta-globin) PCR are hbg1 (5 GCTTCTGACA
CAACTGTGTTCACTAGC-3 ), used at a ﬁnal concen-
tration of 300nM, and hbg2 (5 -CACCAACTTCATC
CACGTTCACC-3 ), used at a ﬁnal concentration of 700nM.
The ﬁnal reaction mix contained 20nM Tris-HCL, pH 8.4:
50mM KCl; 200μMe a c hd N T P ;1 %D M S O ;0 . 4 xS y b e r
Green (Invitrogen, Carlsbad, Calif, USA); 22ng E. coli DNA
(MP Biomedicals, Solon, Ohio, USA); 0.4 Units of Platinum
Taq DNA polymerase (Invitrogen, Carlsbad, Calif, USA)
and 0.5–10ng of genomic DNA per 11μL reaction. Tubes
containing 26, 8.75, 2.9, 0.97, 0.324, and 0.108ng of a
reference DNA (from HeLa cancer cells) were included in
each PCR run so that the quantity of the targeted templates
in each sample could be determined relative to the reference
DNA sample by the standard curve. Additional details of the
m e t h o dc a nb ef o u n di nL i ne ta l .[ 30]. Telomere length
is presented in terms of base pairs. This method of LTL
measurement is reliable and comparable to alternative
methods, such as southern blot [31].
2.6. Statistical Analyses. All analyses were performed using
SPSS version 18.0. Linear regression models examined as-
sociations of sleep variables with LTL, adjusting for a set
of standard covariates known to be associated with LTL
in past studies (chronological age, body mass index, race,
and income). To determine if the relationship between
sleep and LTL was better accounted for by psychological
stress, separate analyses were conducted, entering the set of
standard covariates in the ﬁrst step, perceived stress in the
second step, and the sleep variable in the third step. Finally,Journal of Aging Research 3
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Figure 1: Subjective sleep quality is associated with leukocyte
telomere length among participants for whom sleep quality rating
reﬂected their “typical” sleep (n = 201), adjusting for age, race,
BMI, income, and perceived stress.
Table 1: Characteristics of the study sample (n = 245 unless other-
wise noted).
Variable Mean or % SD
Age (years) 57.5 4.4
Race (% Caucasian) 84.5%
Body mass index (kg/m2) 24.4 4.7
Household income (% ≥75K/year)a 67.2%
Perceived stress (PSS score)b 23.2 6.0
Time in bed (hours)c 8.0 1.0
Sleep duration (hours)d 7.2 1.0
Sleep onset latency (minutes) 17.2 18.9
Sleep quality (1 = very bad, 5 = very good) 3.8 0.8
Telomere Length (T/S converted to base pairs) 5547.0 330.7
an = 235, bn = 241, cn = 238, dn = 243.
because prior evidence suggests that persistent psychosocial
fact orsha v eagr eaterinﬂuenc eontelomer elengththanmor e
transientfactors[11],aﬁnalanalysiswasconductedwhereby
we restricted the sample to only those participants for whom
thesleepmeasuresobtainedrepresentedtheir“typical”sleep.
Importantly, because previous investigations support a U-
shaped association of sleep duration with mortality [32],
nonlinear models were also examined.
3. Results
3.1. Descriptive Statistics. Means and standard deviations for
thestudysamplearepresentedinTable 1.Correlationalanal-
yses revealed an inverse association between LTL and BMI
(r =− 0.17, P<0.01). LTL was unrelated to age and race,
as expected given the restricted age range and homogeneity
of the sample’s ethnicity/race (84.5% Caucasian). LTL was
also unrelated to income, depressive symptoms, and levels
of perceived stress. Older participants were more likely to
report poorer sleep quality (r = 0.21, P = 0.001) and longer
sleep onset latency (r =− 0.15, P = 0.02). As expected,
participants reporting shorter sleep duration, poorer sleep
quality, and longer sleep onset latencies were more likely to
report higher levels of perceived stress (P s < 0.05).
Table 2: Linear regression models displaying associations of sleep
variables with telomere length (base pairs) adjusting for study
covariates.
Model B SE B βt P value
Time in bed
Age −4.29 5.08 −.056 −.845 .399
Race −67.05 60.30 −.073 −1.11 .267
BMI −11.43 4.72 −.162 −2.42 .016
Income 18.77 47.11 .026 .398 .691
Time in bed −20.62 21.56 −.063 −.956 .340
Sleep duration
Age −4.09 5.03 −.053 −.798 .426
Race −47.06 60.02 −.052 −.784 .434
BMI −11.54 4.67 −.163 −2.47 .014
Income 11.72 46.57 .017 .252 .801
Sleep duration −2.44 22.26 −.007 −.110 .913
Sleep onset latency
Age −5.03 4.99 −.066 −1.01 .315
Race −53.97 59.32 −.059 −.910 .364
BMI −11.45 4.62 −.162 −2.48 .014
Income 10.06 46.08 .014 .218 .827
Sleep onset latency −100.34 71.08 −.092 −1.41 .159
Sleep quality
Age −6.04 5.02 −.080 −1.20 .230
Race −51.03 58.92 −.056 −.866 .387
BMI −11.19 4.60 −.158 −2.43 .016
Income 2.55 46.07 .004 .055 .956
Sleep quality 55.48 27.43 .133 2.02 .044
3.2. Sleep and Telomere Length. Bivariate correlations be-
tweenLTLandmeasuresoftimeinbedsleep(r =− 0.06,P =
0.36), duration (r = 0.01, P = 0.92), and sleep onset latency
(r =− 0.11, P = 0.09) failed to support the hypothesis
that these variables would be associated with LTL. Moreover,
there was little support for a non-linear association between
LTL and sleep duration. However, poorer subjective sleep
quality was associated with shorter LTL (r = 0.14, P =
0.03). Table 2 displays the results of linear regression models
adjusting for study covariates (age, BMI, race, and income).
In this regard, poor sleep quality predicted shorter LTL
independent of covariates.
In order to determine if the relationship between sleep
quality and LTL was better accounted for by levels of per-
ceived stress, we computed a separate regression. In this
regard, adjusting for levels of perceived stress, the rela-
tionship between sleep quality and LTL was reduced below
statistical signiﬁcance (b = 47.36, SE = 29.52, P = 0.11). In a
follow-upanalysis,weexaminedifthesamerelationshipheld
among participants for whom self-reported sleep quality was
typical for the past 3 months (n = 201). As displayed in
Figure 1, when the sample is restricted to these participants,
sleep quality emerges as an independent predictor of LTL,
whichremainssigniﬁcantafteradjustmentforcovariatesand
perceived stress (b = 68.45, SE = 34.44, P = 0.05).4 Journal of Aging Research
4. Discussion
This study provides initial evidence for an association be-
tween sleep quality and leukocyte telomere length, a marker
of immune cell aging, among a sample of healthy midlife
women. Speciﬁcally, we found that women reporting poorer
subjective sleep quality had shorter LTL, independent of age,
body mass index, race, and income, thus, providing prelim-
inary evidence that LTL may reﬂect a potential biological
mechanism linking sleep and age-related disease.
In the full sample (N = 245), levels of perceived stress
accounted for variance in the relationship between sleep
quality and telomere length. However, when analyses were
limited to those participants whose sleep quality in the past
week was typical of their sleep over the past three months
(N = 201), sleep quality was a signiﬁcant predictor of
LTL, independent of perceived stress, indicating that the
chronicityofsleepproblemsmaybeanimportantqualiﬁerin
this association. This is consistent with a prior investigation
of caregiving stress and LTL, which found that duration of
caregiving and not merely being a caregiver was associated
with telomere attrition [11].
The biological mechanisms underlying the association
between sleep quality and telomere attribution remain to
be elucidated. Indeed, disrupted sleep quality has been as-
sociated with cortisol secretion [33], enhanced autonomic
activation [34], and elevated proinﬂammatory cytokine pro-
duction [35], which may contribute to variation in LTL. Re-
centworksuggeststhatLTL,inaddition tobeing apromising
biomarker of cellular aging, may also be an important con-
tributor to disease pathogenesis [36]; rodent models lacking
telomerase have implicated telomere attrition as a mecha-
nism leading to mitochondrial damage, increased oxidative
stress, and structural and functional damage to cardiac tissue
[36]. Relatedly, it is possible that chronically disturbed sleep
is related to diminished telomerase activity; however, no
study has yet examined whether telomerase activity varies by
quality or duration of sleep.
There are a number of limitations of the current study.
The cross-sectional nature of the study precludes any causal
inferences regarding sleep quality and LTL. In addition, we
relied on self-reported sleep measures, and more than 67%
of the participants described their sleep as “fairly good’’
or “very good.” Future studies would beneﬁt from using
more ecologically valid measures of sleep, including in-home
polysomnography and actigraphy, as well as sampling within
a population with greater variation in quality of sleep; the
latter could be accomplished by including a more compre-
hensive measureof subjective sleepquality. Importantly, par-
ticipantsinthecurrentstudywerepredominantlyCaucasian,
well educated, in a high-income bracket, and included only
women. Thus, the present ﬁndings are potentially restricted
to this sample of women, and the possibility exists that
other components of sleep, such as duration and latency,
would be associated with LTL in a more diverse sample of
participants. Furthermore, while perceived stress was as-
sessed, other related psychological constructs and measures
of stressful life events often related to sleep quality were not
tested here. This is important given converging evidence that
suggests that childhood trauma is a strong predictor of short
LTL in later life [37, 38]. Additional studies are needed to
determine the extent to which psychological factors account
for the observed association between sleep quality and LTL.
Finally, we did not assess for the presence of clinical sleep
disorders, such as obstructive sleep apnea (OSA), in this
study. This is an important issue given that adults with OSA
have been shown to exhibit shorter LTL compared to those
without OSA [39]. Notably, the presence of OSA in children
is associated with longer LTL [40]. While the inﬂuence of
OSA on LTL requires further clarity, the association of sleep
quality and LTL in the present study was independent of
BMI, a common correlate of OSA.
The alarming increase in the prevalence of age-related
diseases suggests that greater attention be placed on identi-
fying biomarkers of cellular aging and modiﬁable behaviors
that may slow the rates of illness. The present study provides
the ﬁrst evidence that poorer subjective sleep quality is
associated with shorter LTL, and additional research using
prospective samples and objective measures of sleep is war-
ranted. Sleep is a modiﬁable health behavior, and while the
clinical signiﬁcance of LTL remains to be elucidated, this
study provides promising results that sleep quality may be an
important factor explaining variation in cellular aging and
later health.
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